( estimated to affect 1 in 7700 live bi...)ZyStor to exhibit cell disorder treatments

estimated to affect 1 in 7,700 live births.

"Our intellectual property surrounds a way of attaching a peptide tag to these enzymes - to better target receptors on cell surfaces on clinically significant tissues - so that it can get into the lysosome of the cell, where it can then reduce the storage material that builds up in patients," Peterson explained.

ZyStor is in preclinica......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 09/12/06


Page: 1 2
Related biology technology :

1. ZyStor seeks to raise $15M for clinical trials
2. Milwaukee area biotech ZyStor seeks more funding
3. ZyStor receives first funding and buys theraputics for rare diseases
4. Engineers help turn science into interactive exhibits
5. Nanotech exhibit opens at UW-Madison
6. Gender hormones may lend to social disorder therapies
7. TomoTherapy leads the industry in CT image-guided treatments
8. Medical College getting $18.1 million to study radiation damage treatments
9. Research on fruit flies opens up possibilities for human treatments
10. UW discovery could lead to new TB treatments